Mirum Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": 44659000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-03-31 |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3f36b95f-7bcf-48bc-9058-8010ffd9fbfa
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-022856Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cashflow-financing/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3f36b95f-7bcf-48bc-9058-8010ffd9fbfa
History
- no predecessors — first report